News Breaks |
|
|
| January 18, 2013 |
| 10:49 EDT |  | AVEO, ODP, RAD, AMAT, NAVB | High option volume stocks; ODP, NAVB, RAD, AVEO, AMAT
|
|
|
News For ODP;NAVB;RAD;AVEO;AMAT From The Last 14 Days Check below for free stories on ODP;NAVB;RAD;AVEO;AMAT the last two weeks. |
|
|
| June 19, 2013 |
| 09:38 EDT | | AMAT | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL AMAT FDX MA C GOOG DISH AMRN MRK BIDU |
|
| June 18, 2013 |
| 08:30 EDT |  | RAD | Rite Aid discloses receipt of additional DEA subpoenas in April
 Subscribe for More Information |
|
| 07:19 EDT |  | ODP | Eyefortransport to hold a summit
Subscribe for More Information |
|
| June 14, 2013 |
| 09:15 EDT | | ODP | Starboard files complaint asking Office Depot to hold meeting
Subscribe for More Information |
|
| 06:02 EDT |  | ODP | Starboard Value sues Office Depot for no annual meeting, Reuters reports
Starboard Value LP, a major Office Depot investor, is suing the company for failing to hold an annual shareholder meeting to elect directors, an unusual step just before a merger, reports Reuters. Reference Link |
|
| June 12, 2013 |
| 11:23 EDT |  | AMAT | Applied Materials rises after upgrade, levels to watch
Citigroup earlier upgraded the stock to Buy, with a $20 price target. The firm cited a belief that the company will benefit from increased foundry adoption of FinFET products. At the current price of $15.78, next big resistance is at $16.50. Support is at $15.40, the session low so far. |
|
| 10:14 EDT |  | AMAT | On the Fly: Upgrade Summary
Subscribe for More Information |
|
| 09:03 EDT | | NAVB | Navidea's Lymphoseek shows positive meta-analysis results
Navidea announced results from a meta-analysis study of Lymphoseek (technetium Tc 99m tilmanocept) Injection, a novel, receptor-targeted, small-molecule radiopharmaceutical. The study compared Lymphoseek performance data from a pre-planned interim analysis of its Phase 3 clinical trial versus published data from the ACOSOG Z-0360 trial which was done using radiolabeled sulfur colloid. Results demonstrated that Lymphoseek identified sentinel lymph nodes in subjects with squamous cell carcinoma of the head or neck with a False Negative Rate of 2.56%, whereas sulfur colloid demonstrated an FNR of 10%. Lymphoseek identified SLNs with an overall accuracy of 99%, versus an overall accuracy of sulfur colloid of 97%. |
|
| 07:08 EDT | | RAD | Drugstores ready access changes to Plan B pill, WSJ reports
Drugstores (CVS, RAD, WAG) are preparing to change how they stock and sell a widely used emergency contraceptive after the Obama administration agreed to allow the pill to be sold over the counter to customers of all ages. Sold primarily under the brand name Plan B (TEVA, ACT, PRGO), the pill is currently stocked behind pharmacy counters, reports the Wall Street Journal.Reference Link |
|
| 06:16 EDT | | AMAT | Applied Materials upgraded to Buy from Neutral at Citigroup
Subscribe for More Information |
| |
| 06:05 EDT | | RAD | On the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: The tectonic plates of the world economy are shifting, moving the yield on the 10-year Treasury to the highest level in more than a year and shaking financial markets. Now, some constants are being questioned in markets, triggering paroxysms in stocks, bonds, commodities and the currencies of emerging markets, the Wall Street Journal reports...Drugstores (CVS, RAD, WAG) are preparing to change how they stock and sell a widely used emergency contraceptive after the Obama administration agreed to allow the pill to be sold over the counter to customers of all ages. Sold primarily under the brand name Plan B (TEVA, ACT, PRGO), the pill is currently stocked behind pharmacy counters, the Wall Street Journal reports...REUTERS: If currency turbulence in emerging markets becomes a full-scale investor flight, the Fed may have a new headache in deciding when to slow its dollar printing policy. The link between U.S. monetary policy and currency runs on the other side of the world could be tighter than many assume, Reuters reports...Toyota Motor (TM) said it’s unlikely to recapture its peak market share it held four years ago in the U.S. (GM, F), its biggest market, the latest sign the carmaker is shifting to improving quality from aggressively expanding sales, Reuters reports...BLOOMBERG: Exchange executives (NYX, NDAQ), long shielded from legal scrutiny in the U.S., have been put on notice that may be changing after federal regulators fined CBOE Holdings (CBOE) $6M for unprecedented lapses in supervision, Bloomberg reports...Borealis Infrastructure Management and its Kuwaiti-British partners abandoned their $8.3B bid for the U.K. water utility Severn Trent (SVTRY) as the offer deadline expired, Bloomberg reports. |
|
| June 11, 2013 |
| 09:03 EDT | | NAVB | Navidea announces positive results from study of Lymphoseek Injection
Subscribe for More Information |
|
| 08:07 EDT | | ODP | OfficeMax and Office Depot hires Korn/Ferry for CEO search
Subscribe for More Information |
|
| 08:03 EDT | | ODP | OfficeMax and Office Depot select Korn/Ferry to assist CEO selection
Subscribe for More Information |
|
| June 10, 2013 |
| 16:19 EDT | | NAVB | Navidea announces results from two breast cancer studies
Subscribe for More Information |
|
| 08:10 EDT | | ODP | Office Depot sets July 10 as date for meeting on OfficeMax proposed merger
Subscribe for More Information |
|
| 06:41 EDT | | AVEO | Aveo Pharmaceuticals to host conference call
Subscribe for More Information |
|
| 06:30 EDT | | AVEO | Aveo Pharmaceuticals announces complete response letter received for tivozanib
Subscribe for More Information |
|
| June 7, 2013 |
| 09:13 EDT |  | RAD | Rite Aid sees FY14 EPS 4c-19c, consensus 14c
Subscribe for More Information |
|
| 09:10 EDT | | RAD | Rite Aid sees Q1 EPS 8c-9c, consensus 4c
Subscribe for More Information |
| |
|
|
|
|
